SCHEMBL1990399

SCHEMBL1990399

O=C(O)C[C@H](c1ccccc1)c1cc(COCc2ccccc2)ccc1OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
FFAR1 O14842 3/20 0.45
FFAR4 Q5NUL3 1/20 0.45
FOLH1 Q04609 1/20 0.44
CTSA P10619 3/20 0.44
PTGER1 P34995 1/20 0.41
PTGER4 P35408 1/20 0.41
PTGER3 P43115 1/20 0.41
PTGER2 P43116 1/20 0.41
ACP1 P24666 1/20 0.41
PTPN12 Q05209 1/20 0.41
PTPN13 Q12923 1/20 0.41
SSU72 Q9NP77 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.40
SLC6A9 P48067 1/20 0.40
SLC6A5 Q9Y345 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990402 1.00 KMT2A (0.47) KMT2ASMN1; SMN2FFAR1FFAR4FOLH1
SCHEMBL1989783 0.91 KMT2A (0.44) KMT2ASMN1; SMN2FFAR1FFAR4FOLH1
SCHEMBL1992690 0.90 FOLH1 (0.42) KMT2ASMN1; SMN2FFAR1FFAR4FOLH1
SCHEMBL1992692 0.90 FOLH1 (0.42) KMT2ASMN1; SMN2FFAR1FFAR4FOLH1
SCHEMBL27809704 0.89 KMT2A (0.49) KMT2ASMN1; SMN2FFAR1FFAR4FOLH1
SCHEMBL27809705 0.89 KMT2A (0.49) KMT2ASMN1; SMN2FFAR1FFAR4FOLH1
SCHEMBL1783943 0.85 KMT2A (0.47) KMT2ASMN1; SMN2FOLH1PTGER1
SCHEMBL2166135 0.85 KMT2A (0.47) KMT2ASMN1; SMN2FOLH1PTGER1
SCHEMBL2167632 0.85 KMT2A (0.47) KMT2ASMN1; SMN2FOLH1PTGER1
SCHEMBL1990350 0.85 PTGER1 (0.51) KMT2ASMN1; SMN2FFAR1FFAR4CTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF CONCERT PHARMACEUTICALS INC. (US) 2011-06-23 US disclosed
CN-102089262-A Derivatives of 3- (2-hydroxy-5-methylphenyl) -N, N-diisopropyl-3-amphetamine and methods of use thereof CONCERT PHARMACEUTICALS INC 2011-06-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF ADRB3, CHRM3, QDPR KMT2A 2758/4885SMN1; SMN2 2545/4885FFAR1 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.